| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5dfc0b033ac4c841466d97a5f28ea32b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-81 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-81 |
| filingDate |
1974-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1976-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81c337b3a52123121dc911ee2047d252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c95104250a2a10a8eaa129a33d69d30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed79744e3fe48702faa185bd62e12403 |
| publicationDate |
1976-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-3935221-A |
| titleOfInvention |
Substituted fusaric acid derivatives |
| abstract |
Halo-fusaric acid amides having the formula WHEREIN X represents halogen or hydrogen, Y represents halogen and R1 and R2 are same or different and represent hydrogen or a lower alkyl group (C1-4) which are characterized by significant activity in the treatment of hypertension. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4036965-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106243024-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106243024-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4260620-A |
| priorityDate |
1971-05-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |